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Camels are the most valuable livestock species in the Horn of Africa and play a pivotal role in the nutritional
sustainability for millions of people. Their health status is therefore of utmost importance for the people living
in this region. Streptococcus agalactiae, a Group B Streptococcus (GBS), is an important camel pathogen. Here we
present the first epidemiological study based on genetic and phenotypic data from African camel derived GBS.
Ninety-two GBS were characterized using multilocus sequence typing (MLST), capsular polysaccharide typing and
in vitro antimicrobial susceptibility testing. We analysed the GBS using Bayesian linkage, phylogenetic and minimum
spanning tree analyses and compared them with human GBS from East Africa in order to investigate the level of
genetic exchange between GBS populations in the region. Camel GBS sequence types (STs) were distinct from
other STs reported so far. We mapped specific STs and capsular types to major disease complexes caused by GBS.
Widespread resistance (34%) to tetracycline was associated with acquisition of the tetM gene that is carried on a
Tn916-like element, and observed primarily among GBS isolated from mastitis. The presence of tetM within different
MLST clades suggests acquisition on multiple occasions. Wound infections and mastitis in camels associated with
GBS are widespread and should ideally be treated with antimicrobials other than tetracycline in East Africa.Introduction
In many semiarid and arid regions of the Horn of Africa,
camel keeping is the most sustainable livestock enterprise.
Due to climate change and desertification, cattle numbers
are decreasing in such regions while camel numbers are
increasing and are likely to play an even more significant
role for human nutrition in the future [1]. For the people
living in these harsh dry areas, the camels play a pivotal
role in survival as an important source of animal protein,
especially milk and to a lesser extent meat, transportation,
cultural status and financial reserve [2]. People live in
very close contacts with their animals and camel milk is* Correspondence: jores@web.de
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reproduction in any medium, provided the ortraditionally consumed raw without proper heat-treatment,
which poses a risk for acquiring infections with zoonotic
pathogens [3]. The potential risk of transmission of camel
pathogens to humans therefore requires investigation.
Streptococcus agalactiae, a Group B Streptococcus (GBS)
is an important pathogen affecting humans and livestock
species such as cattle. This pathogen has also been isolated
from both healthy and diseased camels from the Horn
of Africa [4-9].
The uncontrolled distribution and usage of antibiotics
to treat bacterial livestock infections in the Horn of
Africa [10] is likely to contribute to the emergence
and transmission of antimicrobial resistance genes and
requires further investigation [11]. Data on antimicrobial
susceptibility in camel GBS in Africa is scanty at best,
with only few antibiotics tested on a limited number of
samples [5].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be divided into ten different types based on molecular
typing [12]. Certain capsular types have been associated
with invasive disease or asymptomatic carriage. Capsular
type III Streptococcus is predominant among the types
causing invasive neonatal infections [13,14]. However,
capsular type V has also recently emerged as the cause
of a significant proportion of invasive human infections
in North America [15].
This study aimed to gain insight into the genetic and
phenotypic diversity of camel GBS isolates from East
Africa in order to guide the development of diagnostic
assays as well as vaccines and to provide data useful for
informing antimicrobial treatment strategies for control
of diseases in camels caused by GBS in the horn of Africa.
We characterized 92 camel GBS isolates, their capsular
types, tested their antibiotic resistance profile and the
resistance genes. Additionally, we typed the isolates by
multilocus sequence typing (MLST) and characterized
their genetic diversity and genetic relationships in order
to correlate genotypes/populations with capsular types,
resistance profile and clinical symptoms. Moreover, we
compared East African camel GBS with East African
GBS isolated from humans [16].
Materials and methods
Camel GBS isolates used in this study
All work described was in full compliance with national
regulations. The work was approved by the ethical com-
mittee of the International Livestock Research Institute,
which adheres to international standards and is accredited
by the National Council of Science and Technology in
Kenya (approval number ILRI-IREC2013-12).
Information about the 92 camel GBS isolates used in
this study is provided in Additional file 1. The GBS
were isolated using standard methods [17] and the species
level (GBS) was determined using Lancefield serological
grouping as described before [4,5]. Briefly, specimen
material was streaked out on Edwards agar plates (Oxoid
No. CM0027) containing 5% defibrillated sheep blood.
Plates were examined after 24 and 48 h of incubation
at 37 °C. Small blue and beta hemolytic colonies were
subcultured for further testing. Gram-positive and
catalase-negative cocci that were unable to hydrolyze
esculin and reacted positive when subjected to Lancefield
B testing using Oxoid No. DR587 Latex Grouping Reagent
B were considered to be Streptococcus agalactiae (GBS).
Isolation of genomic DNA from camel GBS
The isolates were grown in 10 mL Luria Broth (LB) over
night at 37 °C. Culture material was centrifuged at 4 °C
and 8000 g for 10 min, the supernatant was discarded
and the cell pellet was resuspended in 275 μL H2O,
10 μL RNAse A (10 mg/mL) and 275 μL TEN buffer(0.05 M Tris, pH 8.0, 0.001 M EDTA, 0.016 M NaCl,
100 mg/mL Lysozyme). The solution was incubated at
37 °C for 30 min, 15 μL 20% SDS and 10 μL proteinase K
(20 mg/mL) were added, mixed and the solution was
incubated at 37°C for 60 min. 125 μL of 4 M NaCl and
80 μL CTAB solution (10% in H2O, preheated to 50°C)
were added, mixed and the solution was incubated
at 65°C for 10 min. A phenol/chloroform extraction
followed by a DNA precipitation using ethanol
according to standard protocols [18]. The DNA pellet
was resuspended in TE (pH 8.0) buffer and stored
at −80 °C for subsequent use.
In vitro antimicrobial susceptibility testing of camel GBS
The susceptibility of the camel streptococcal isolates to
23 different antimicrobials, listed in Table 1, was assessed
phenotypically using broth microdilution method accord-
ing to CLSI document M31-A3 [19]. Briefly, Sensititre®
microtiter plates containing the antimicrobial agents in a
vacuum dried form and cation-adjusted Mueller-Hinton
Broth supplemented with 2% lysed horse blood (Trek
Diagnostic Systems) were used. An inoculation density
of 2–8 × 105 CFU/mL was prepared according to CLSI
standards. Plates were inoculated using the Sensititre®
inoculation system, sealed with a plastic foil and incubated
under aerobic conditions at 37 °C for 24 h. We included
Staphylococcus aureus ATCC 29213 and Streptococcus
pneumonie ATCC49619 as quality control strains. Since
clinical veterinary breakpoints are not available for
camels we used the wild type cut-off values for ampicillin,
cefoperazone, clindamycin, cefotaxime, erythromycin, tet-
racycline and vancomycin provided by EUCAST [20] as
well as CLSI clinical breakpoints provided for animals [19]
(Table 1) for interpretation of results.
Testing of the presence of the tetracycline resistance
genes tetM, tetO, and Tn916-like elements in camel GBS
The presence of the common genes reported to confer
resistance to tetracycline i.e. tetM and tetO, was investi-
gated in camel isolates phenotypically resistant to tetra-
cycline using PCR amplification as described previously
[21]. Twenty nanograms of genomic DNA was used as
template in a final volume of 50 μL of PCR master mix
containing; 1 × PCR buffer (DreamTaq™including MgCl2,
Fermentas, Germany) 200 μM of dNTP; 600 nM each of
the forward/reverse primers and 1.25 U of DreamTaq™
DNA Polymerase. The amplification conditions were as fol-
lows; denaturation for 3 min at 95 °C, followed by 35 cycles
of 95 °C for 1 min, 48/55 °C for 1 min for tetM/ tetO re-
spectively, and 72 °C for 1 min with a final extension of 72 °
C for 10 min. Positive controls strains for tetM and tetO
PCRs were S. agalactiae 2603 V/R [15] and Streptococcus
anginosus MG23 [22], respectively. Selected PCR prod-
ucts were sequenced and trimmed from position 865 to
Table 1 Results of the in vitro antimicrobial susceptibility testing
0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128
ECOFF
CLSI CBP MIC90
mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L mg/L (mg/L) (mg/L)
AMC 2 43 44 1 ND ≥ 32/16 0.25
AMP 1 20 68 1 ≤ 0.25 ≥ 8 0.25
CEF 1 53 35 1 ND ≥ 32 0.5
CFP 1 44 44 1 ≤ 0.125 ND 0.5
CFQ 1 24 65 ND ND 0.12
CHL 2 83 4 1 ND ≥16 2
CLI 10 80 ≤0.5 ND 0.06
CTX 1 52 35 1 1 ≤ 0.125 ND 0.12
ENR 1 5 75 8 ND ND 1
ERY 2 14 74 ≤ 0.25 ≥ 1 0.06
GEN 1 1 15 71 2 ND ≥ 16 32
OXA 1 4 85 ND ND 0.5
PEN 1 39 48 1 1 ND ≥4 0.12
PIRL 3 80 7 ND ≥4 0.12
Q-D 1 6 83 ND ND 0.5
SPI 1 84 4 ND ND 0.25
SXT 28 57 3 1 ND ≥ 76 0.06
TET 26 31 1 12 19 ≤ 1.0 ≥ 8 64
TIL 2 1 4 83 ND ND 4
TUL 1 1 78 10 ND ND 1
TYL 1 3 56 30 ND ND 1
VAN 82 8 ≤1.0 ND 0.5
XNL 1 5 83 1 ND ≥ 8 0.25
ECOFF-epidemiological cut-off value (retrieved from the European Committee on Antimicrobial Susceptability Testing), CLSI CBP-CLSI M31-A3 veterinary clinical
breakpoint for resistance, MIC90-Minimum Inhibitory Concentration required to inhibit the growth of 90% of organisms, ND-not determined, GBS-Group B
Streptococcus agalactiae, AMC-Amoxicillin-clavulanic acid (2:1 ratio), AMP-Ampicillin, CEF – Cephalothin, CFP - Cefoperazone, CFQ – Cefquinome, CHL –
Chloramphenicol, CLI – Clindamycin, CTX – Cefotaxime, ENR – Enrofloxacin, ERY – Erythromycin, GEN – Gentamicin, OXA – Oxacillin + 2% NaCl, PEN – Penicillin,
PIRL – Pirlimycin, Q-D - Quinupristin/Dalfopristin, SPI – Spiramycin, SXT - Trimethoprim/Sulfamethoxazole, TET – Tetracycline, TIL – Tilmicosin, TUL – Tulathromycin,
TYL – Tylosin, VAN – Vancomycin, XNL – Ceftiofur.
Fischer et al. Veterinary Research 2013, 44:86 Page 3 of 10
http://www.veterinaryresearch.org/content/44/1/861075 in tetM of strain 2603 V/R (GenBank Accession
Number: NC_004116). A possible location of the tetM
gene within a Tn916-like element was evaluated using a
PCR spanning from the tetM gene (tetM3-end: 5′-
ACTACCGGTGAACCTGTTTG-3′) to the transposase
(Tn916tnase: 5′-TGGCTCTCTCCAGTCTTTAAG-3′).
The expected PCR product was 2,740 bp long. PCR
conditions were as outlined above with the difference
that the annealing temperature was 58 °C and the ex-
tension time was set to 3 min. Positive control strain
for Tn916 was Staphylococcus rostri RST11 [23].
Molecular capsular typing of camel GBS
Capsular polysaccharide gene types (cps) were determined
using a multiplex PCR assay as described previously [12]
using DreamTaq™ DNA Polymerase. Amplified products
were separated on a 1.5% agarose gel and the band pattern
of the isolates were compared to the band pattern of theGBS reference isolates included in this study representing
all known capsular types; Ia, Ib, II, III, IV, V, VI, VII, VIII
and IX [12].
Multilocus Sequence Typing (MLST) of camel GBS
The MLST was performed as described previously [24].
Briefly, seven S. agalactiae housekeeping gene loci were
amplified, including alcohol dehydrogenase (adhP), pheny-
lalanyl tRNA synthetase (pheS), amino acid transporter
(atr), glutamine synthetase (glnA), serine dehydratase
(sdhA), glucose kinase (glcK) and transketolase (tkt).
The PCR amplification was carried out in duplicate
(50 μL reaction volume) using GoTaq® Green master
mix polymerase (Promega, USA) according to manufac-
turers’ instructions. PCR products were purified using a
QIAquick PCR purification kit (QIAGEN, Germany) and
sequenced by Macrogen Inc. (Seoul, Korea). Sequence
traces were assembled using the CLC workbench 6.
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the MLST database entries and novel alleles were assigned
new allele numbers. New combinations of alleles were
also assigned new sequence type (ST) numbers. All camel
isolates were submitted to the MLST database [25].
Minimum Spanning Trees (MST) of camel GBS
To visualize the genetic relationship between camel
GBS, MSTs were generated from the allelic profiles of
the different isolates using the predefined settings in
BioNumerics® 6.6. The clonal complex/populations, capsular
type (Ia, Ib, II, III, IV, V, VI, VII, VIII and IX), tetracycline
resistance (resistant or susceptible) and clinical complex
(chronic cough, mastitis, wound infection/abscess/peri-
arthricular abscess, gingivitis, vaginal discharge and healthy
camels) were plotted onto the minimum spanning tree
using different color codes.
Phylogenetic analysis of East African GBS isolated from
camels and humans
We compared the camel GBS with other published MLST-
typed GBS from East Africa [16]. A concatenated sequence
of each ST was generated using MLST data from this study
and from elsewhere [16]. Jmodeltest 1.0 [26] was used
to select the best fitting model of nucleotide substitution,
which was found to be the Generalized Time Reversible
model with invariant sites and gamma-distributed rate
heterogeneity (GTR + I + G) [27]. A maximum likelihood
phylogeny for all STs was estimated using this model
in PhyML 3.0 [28]. To assess statistical support for the
resulting phylogeny, we performed 1000 bootstrap rep-
licates. The tree was drawn using the software FigTree
v1.3.1 [29].
Determination of population structure of East African GBS
isolated from camels and humans
For this analysis we included 169 human isolates [16],
which were MLST-typed before in order to investigate
a possible gene flow between camel and human GBS.
The population structure was estimated using the linkage
model in STRUCTURE v2.3.2 [30,31]. This Bayesian
approach uses multilocus genotypic data to define a set of
populations with distinct allele frequencies, and assigns
isolates probabilistically to defined populations without
prior knowledge of sampling location or sampled host.
This program identifies admixtures of isolates and provides
an estimate of the percentage ancestry from ancestral
population for each isolate. We performed eight repli-
cations of the test, in which we initially discarded 10
000 Markov Chain Monte Carlo (MCMC) iterations as
burn-in and kept the subsequent samples from 30 000
MCMC iterations for analysis. We tested values of K
between 1 and 10, where K is the number of inferred
populations. The results of the eight independent runswere averaged for each K value to determine the model
with the highest likelihood. Real and simulated data
have shown that it is not straightforward to determine
the optimal value of K when complex population structure
is present [30,32] so we also calculated ΔK, a measure
of the second order rate of change in the likelihood of
K [32] to estimate the appropriate K value for our data.
Results
In vitro antimicrobial susceptibility of camel GBS
The susceptibility profiles for 90 out of 92 camel GBS
isolates against 23 antimicrobials are presented in Table 1
and Additional file 2. Two strains showed poor growth
in Mueller-Hinton Broth with lysed horse blood and
were therefore excluded from analysis of minimal inhibitory
concentrations (MIC). The interpretation of data is
hampered by the absence of clinical breakpoints for
camels. We included the epidemiological criterion (wild
type cut-offs, ECOFF) for interpretation of data, which
unfortunately was only available for a fraction of anti-
microbials tested. This criterion was determined on the
basis of human strains and a different methodology than
the one applied in this study. However, on the basis of
veterinary clinical breakpoints available for streptococci
[19] and MIC90 values determined in this study, only
resistance to gentamicin and tetracycline is obvious
(Table 1). In fact, 34% of the GBS isolates were resistant
to tetracycline. One isolate (ILRI029, ST-617, capsular type
VI) showed reduced sensitivity to all β-lactam antibiotics
tested, probably due to a mutation in the gene pbp, encod-
ing the penicillin binding protein. As expected most
GBS isolates showed relatively high MIC to gentamicin
in the range of 8–64 mg/L that is characteristic to the
genus Streptococcus. For all other antimicrobial agents
investigated, MIC distributions were normal.
Prevalence of tetM, tetO or Tn916-like elements
All tetracycline-resistant camel GBS harboured the tetM
gene. All camel GBS were negative for tetO. The 211 bp
sequence obtained from the tetM amplicon was 100%
identical between the isolates investigated (N = 17) and
100% identical to other tetM sequences in the database
from Staphylococcus aureus and S. agalactiae (e.g. GenBank
accession number: NC_004116 and CP003808). In addition,
we showed that, in all tetracycline-resistant camel GBS,
tetM was linked to the Tn916 transposase, pointing towards
a transfer of the resistance gene via a Tn916-like element.
Capsular typing
We assigned a capsular type to all but one camel GBS
isolate (ILRI041). The capsular types detected included
Ia, II, III, V and VI. The most common types were Ia
(37%, 34 isolates), III (27%, 25 isolates) and VI (26%, 24
isolates). Type II and V were less commonly detected with
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for the respective types. Capsular types Ib, IV, VII, VIII
and IX were not present among the camel isolates tested.Multilocus Sequence Typing (MLST) of camel GBS
Among all 92 camel GBS isolates, fourteen novel alleles
were identified by MLST of seven S. agalactiae house-
keeping gene loci (adhP, pheS, atr, glnA, sdhA, glcK and
tkt) [24] (Table 2). All camel isolates differed from GBS
currently deposited in the MLST database in alleles of
the gene loci glcK, glnA and pheS. A total of 10 new
unique sequence types (STs), named ST-609 through
ST-618, were identified; the most common STs were
ST-617 (29%, 27 isolates), ST-616 (26%, 24 isolates) and
ST-612 (26%, 24 isolates). Four isolates belonged to
ST-615 and ST-613, respectively, while only two iso-
lates belonged to ST-614, ST-611, ST-610 and ST-609
respectively. Only one isolate represented ST-618
(Additional file 1).Relationship between camel GBS STs, clonal complexes,
capsular types, tetracycline resistance and clinical complexes
According to the minimum spanning tree (MST) network
and the number of shared alleles, the ten camel STs
clustered in three clonal complexes/populations consisting
of ST-609/ST-614, ST-616 and the remaining seven STs
that had six alleles in common (Figure 1A). ST-609 and
ST-614 were most distantly related to the other camel
ST-609 and shared only 2 alleles with ST-616 (Figure 1A).
The ten STs that grouped into 3 clonal complexes
were further plotted against capsular type, resistance to
tetracycline and clinical complexes. Capsular type Ia was
predominant in isolates with ST-618, ST-613 and ST-612,
while capsular type VI was most common in isolates with
ST-610 and ST-617 (Figure 1B). Isolates with capsular type
II were of ST-612 and ST-615. All isolates within ST-616Table 2 Camel GBS allelic combinations revealed from MLST
ST adhP pheS atr glnA sdhA
609 56 40 4 66 1
610 13 40 6 65 3
611 13 40 68 65 54
612 111 40 6 65 3
613 111 40 67 65 3
614 56 41 4 66 1
615 13 40 6 65 3
616 13 40 68 65 55
617 13 40 68 65 3
618 111 40 69 65 3
Camel specific alleles and sequence types (STs) are displayed in bold.
TUL – Tulathromycin, TYL – Tylosin, VAN – Vancomycin.belonged to capsular type III while all isolates with ST-609/
ST-614 belonged to capsular type V (Figure 1B).
Tetracycline resistant isolates were found within ST-
612 (4%; 1 out of 24) and ST-617 (30%; 8 out of 26),
however the majority of the resistant isolates were
grouped within ST-616 (92%; 22 out of 24) representing a
total of 71% of all resistant GBS (Figure 1C). Interestingly,
most of the GBS isolated from cases of mastitis (81% of
mastitis isolates) belonged to ST-616 (Figure 1D). Wound
infection and abscesses were found mainly in STs other
than ST-616.
No association between STs and geographical origin of
the GBS isolates could be detected (data not shown).
Comparison of camel GBS with other GBS from the region
To investigate the relationship between camel GBS and
other GBS from the region, we compared our dataset to
previously described human GBS from Kenya [16].
A maximum likelihood (ML) phylogeny was generated
using a total of 33 STs (10 camel GBS STs and 23
human GBS STs [16]). An unrooted tree clearly showed
that all camel GBS group in two well supported clusters
that are phylogenetically distinct from the Kenyan human
GBS (Figure 2). One cluster comprises ST-609/ST-614,
the other one all the other isolates.
In order to look for evidence of genetic exchange
between camel and human GBS, we performed a STRUC-
TURE analysis. Calculation of ΔK produced a modal value
for K = 7, whereas the averaged highest likelihood for
eight independent runs was obtained for K = 8. We
therefore present results for both K = 7 and K = 8 in
Figure 3. The seven populations in common for both
analyses were; two populations of camel isolates only,
corresponding to 2 of the clonal complexes identified
on Figure 1A, containing 64 and 24 isolates respectively.
All 24 isolates belonging to the second population are of
capsular type III, whereas 63 of the 64 isolates belongingtyping of 92 East African isolates
glcK tkt Number of isolates % of isolates
53 4 2 2
52 50 2 2
52 51 2 2
52 51 24 26
52 51 4 4
53 4 2 2
52 51 4 4
52 4 24 26
52 51 27 29
52 51 1 1
ST 615
ST 612
ST 617
ST 610
ST 613
ST 618
ST 611
ST 616
ST 609
ST 614
6 alleles in common        5alleles in common             2 alleles in common
Capsular type V
Capsular type VI
Capsular type Ia 
Capsular type II
Capsular type III
DA CB
Resistant to tetracycline  
Susceptible to tetracycline 
Not tested 
Population 2
Population 3
Population 1 Wound infection/
No data
Gingivitis
Vaginal discharge
Mastitis 
Chronic cough
Healthy
abscess
ST 615
ST 612
ST 617
ST 610
ST 613
ST 618
ST 611
ST 616
ST 609
ST 614
ST 615
ST 612
ST 617
ST 610
ST 613
ST 618
ST 611
ST 616
ST 609
ST 614
ST 615
ST 612
ST 617
ST 610
ST 613
ST 618
ST 611
ST 616
ST 609
ST 614
Figure 1 Minimum spanning tree (MSTree) of East African isolates of camel S. agalactiae. Each circle represents a single sequence type
(ST), its size is proportional to the number of isolates. The topological organization within the MSTree is based on a graphical algorithm using an
iterative network approach to identify sequential links of increasing distance. (A) clonal complex, (B) capsular type, (C) resistance to tetracycline,
and (D) clinical symptoms.
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The remaining isolate could not be assigned to a distinct
capsular type. Four populations consisted only of human
isolates, corresponding to previously defined clonal
complexes [16]. The last population consisted of seven
isolates, four from camels (ST-609/ST-614) and three
from humans, all belonging to capsular type V. These
isolates are hybrids with mixed ancestry, the camel isolates
having at least 36% shared ancestry with human isolates.
The human clonal complexes CC1 and CC19 [16], formed
one population for K = 7, but were split into two distinct
populations for K = 8.
Discussion
With a population of many million animals, camels rep-
resent a major livestock species in the Horn of Africa.
The diet of people living in semiarid and arid regions in
the Horn of Africa is to a large extent based on raw
camel milk. Therefore, the health status of the camel
and specifically of its mammary glands is important for
human nutrition in the region. The mapping of capsular
types, clinical complexes, and antimicrobial resistance
to specific MLST generated sequence types revealed
interesting insights into the molecular epidemiology of
GBS from camels. We identified three clonal complexes/populations within the camel GBS (Figure 1). The biggest
population comprising 64 isolates encompassed four
capsular types and isolates from diseased and healthy
animals. Abscesses and wound infections accounted for
the majority of clinical isolates within this population.
The second largest population consisted of 26 isolates,
which all belonged to the ST-616 and were of capsular
type III only. This population consisted of clinical isolates
only, originating from milk of mastitic camels. This popu-
lation showed the least diversity in terms of capsular types,
and clinical complexes and is of most importance to the
livestock keeper, since mastitis is the main constraint for
productivity of camels. The third population detected in
this study contains ST-609 and ST-614. When compared
to human isolates, the four camel isolates accounting for
STs ST-609 and ST-614 clustered in one population with
human GBS isolated in Kenya. The four human isolates
belonged to ST-26 and to capsular type V. These isolates
represent hybrids of mixed ancestry (Figure 3), pointing
towards a high plasticity of S. agalactiae and the possible
occurrence of genetic exchange [33]. Nevertheless, only
three alleles are shared between the camel and human
strains within this population, and camel strains are clearly
distinct from human strains on the phylogenetic tree
(boostrap values on Figure 2). Another study showed that,
ST4
ST3
ST1
ST2
ST17
ST182
ST26
0.0020
ST28
ST19
ST484
ST609
ST614
ST24 ST23ST492
ST501
ST616
ST611
ST617
ST615
ST610 ST612ST618ST613
ST12
ST10
ST8
ST486
ST103ST485
ST328
ST327
100
99 99
100
99
97
91
100
Figure 2 Unrooted phylogenetic tree displaying the phylogenetic relationship of the East African camel and human S. agalactiae
isolates. Camel STs are displayed in colour. The bootstrap values above 90 are displayed.
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of the MLST scheme, they represent distinct lineages,
as demonstrated by including more housekeeping genes
[34]. Therefore, our data do not provide evidence of
cross-species transmission of camel GBS to humans or
vice-versa. Nevertheless, GBS from people in intimate610-613
615
617
618
3
8
1
1
48
19
28
103
182
327
328
486
616
609
614
126
2
Figure 3 Population structure of 92 East African camel GBS and 169 K
analysis using the linkage model and sequences from 7 house-keeping gen
colours, the hosts are displayed above. The ancestral parts of each isolate a
population.contact with camels or camel products should be collected
and compared to these strains in order to completely rule
out such a possibility.
In order to advise animal holders, caretakers and vet-
erinarians on the best options to treat GBS infections
in camels we investigated the susceptibility to 23 anti-0
2
5
4
23
24
492
501
17
484
Sequence type
K=7
K=8
enyan human GBS. The populations revealed by the STRUCTURE
e fragments are displayed below the figure and marked with different
re displayed in vertical lines. The STs are displayed for every
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Clinical breakpoints which are animal species and disease
specific [35] are unfortunately not available for camels.
However, the CLSI clinical breakpoints available for
streptococci from animal species other than camels
[19] as well as the high MIC90 values for tetracycline
(64 mg/L) and gentamicin (32 mg/L) indicated resistance
to these antimicrobials. While the resistance to gentamicin
is genus specific and hence expected we additionally
detected resistance to tetracycline in 34% of all camel
GBS tested. According to EUCAST ECOFF values the
MIC90 value for tetracycline was high above the cut-off
supporting the finding of acquired resistance to tetra-
cycline. Two previous reports based on relatively low
numbers of isolates and antimicrobials tested via agar
diffusion sensitivity testing reported a higher prevalence
of tetracycline resistant isolates (44% to 53%) which
might be attributed to the low number of isolates tested,
the method used or the sampling scheme [5]. Resistance
to tetracycline was detected in three different STs within
the two large clonal complexes/populations. Interestingly,
not all isolates from any of the three STs were resistant.
Most resistant isolates (71%) belonged to the mastitis
causing isolates of ST-616. We showed that resistance
was conferred by the gene tetM. The latter has been
reported to be characteristic for resistance against tetra-
cycline especially in human GBS [11]. Interestingly, the
presence of the tetM gene in three different STs, which
represent two distinct populations, suggests a repeated
acquisition of the tetM gene via transposition by a
Tn916-like element as indicated by our PCR results
[36]. Our current data do not provide a conclusive picture
on the source of tetracycline resistance genes detected in
camel GBS. Sequence analysis of the flanking regions of
tetM via full genome sequencing might help in answering
this question [37].
Tetracycline is a broad spectrum antimicrobial com-
monly used to treat bacterial infections in animals in
the Horn of Africa. The use of tetracycline and other
antimicrobials is not as regulated and closely moni-
tored as in the industrialized world and the entry of
antimicrobial residues into the food chain is therefore
difficult to control. Our findings show that mastitis in
camels caused by GBS should be treated with antimi-
crobials other than tetracycline to prevent the further
spread of tetracycline resistant clones. Alternative drugs
are increasingly available in pastoralist regions of East
Africa and should be favoured to tetracycline for treat-
ment of mastitis caused by GBS. However, it has to be
noted in this respect that one camel GBS isolate of our
study revealed an increased MIC to β-lactam antibiotics,
assumingly a first step to resistance, indicating that use
of this kind of antibiotics in the region might also lead
to resistance problems.Given the increasing importance of camels as dairy
animals, and the limitations and risks of parenteral and
intra-mammary antibiotic treatments for camel mastitis,
long term research into alternative disease control options
such as vaccination combined with specific point of
care diagnostic tests is highly desirable and timely. In
this respect, antigens of capsular type III GBS are a good
starting point [38] and require further characterization
regarding their potential use in glycogonjugated vaccines
or as diagnostics molecules. A vaccine against all camel
capsular types would be desirable but is likely to be even
more challenging.
Camel GBS should be added to pangenome studies of
GBS since they are more distantly related to human
strains than livestock species such as cattle given the
number of shared alleles [34]. Whole genome sequencing
and analysis of camel GBS might reveal supplementary
biochemical pathways and functions that are not essential
for bacterial survival but which might explain the origin of
antibiotic resistance genes or reveal colonization factors
necessary to infect the camel. In addition, genome data
will allow to identify molecular targets specific to camel
GBS for diagnostic tool development.Conclusions
Camel GBS sequence types (STs) were distinct from STs
reported from other hosts so far. Most mastitis causing
GBS were associated with ST-616. Widespread resistance
(34%) to tetracycline was most prominent in ST-616 and
associated with acquisition of tetM carried on a Tn916-
like element. The presence of tetM within different MLST
clades suggests acquisition on multiple occasions. Wound
infections and mastitis in East African camels associated
with GBS should be treated with antimicrobials other than
tetracycline in East Africa.Additional files
Additional file 1: Isolates used in this study. Data on the origin of the
isolates tested in this study.
Additional file 2: Minimum inhibitory concentrations of camel S.
agalactiae. Minimum inhibitory concentrations were determined on
the data available for cattle, GBS-Group B Streptococcus agalactiae,
AMP-Ampicillin, AMC-Amoxicillin-clavulanic acid, CTX – Cefotaxime,
CFP- Cefoperazone, CFQ – Cefquinome, XNL – Ceftiofur, CEF – Cephalothin,
CHL – Chloramphenicol, CLI – Clindamycin, ENR – Enrofloxacin,
ERY – Erythromycin, GEN – Gentamicin, OXA – Oxacillin, PEN – Penicillin,
PIRL – Pirlimycin, Q-D - Quinupristin/Dalfopristin, SPI – Spiramycin,
TET – Tetracycline, TIL – Tilmicosin, SXT - Trimethoprim/Sulfamethoxazole.
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